Focus on myeloproliferative diseases and myelodysplastic syndromes

This publication has 49 references indexed in Scilit:

• EVI1 induces myelodysplastic syndrome in mice
  Journal of Clinical Investigation, 2004
• Mouse model of Noonan syndrome reveals cell type– and gene dosage–dependent effects of Ptpn11 mutation
  Nature Medicine, 2004
• Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease
  Journal of Clinical Investigation, 2004
• Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder
  Proceedings of the National Academy of Sciences, 2003
• PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative disease
  Cancer Cell, 2003
• A Tyrosine Kinase Created by Fusion of thePDGFRAandFIP1L1Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome
  New England Journal of Medicine, 2003
• The Fanconi anaemia/BRCA pathway
  Nature Reviews Cancer, 2003
• Mutations in SBDS are associated with Shwachman–Diamond syndrome
  Nature Genetics, 2002
• Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia
  Blood, 2000
• Circulating erythroid progenitors in polycythemia vera are hypersensitive to insulin-like growth factor-1 in vitro: studies in an improved serum-free medium [see comments]
  Blood, 1994